Publication | Open Access
IGF2-NR4A2 Signaling Regulates Macrophage Subtypes to Attenuate Liver Cirrhosis
13
Citations
25
References
2023
Year
Our study provides a theoretical basis for the future use of BMDM-based cell therapy to treat liver cirrhosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1